Alkem develops anti-diabetic, anti-malarial, cardiovascular, immunosuppressants, nutraceuticals and pain management products.
Business Model:
Revenue: $1.4B
Employees: 10,001-999,999
Address: Devashish Building, Alkem House, Senapati Bapat Road,
City: Mumbai
State: maharashtra
Zip: 400 013
Country: IN
Alkem develops anti-diabetic, anti-malarial, cardiovascular, immunosuppressants, nutraceuticals and pain management products.
Contact Phone:
Contact Email:
Listed Exchange:
National Stock Exchange of India
IPO Date:
12/24/2015
Ticker Symbol:
ALKEM
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 12/2015 | Venture Round | $0 |
DB International Kuwait Investment Authority Apax Group Morgan Stanley Abu Dhabi Investment Authority DB International Kuwait Investment Authority Apax Group Morgan Stanley Abu Dhabi Investment Authority |
12/2015 | Equity | 5 | $60M |
Abu Dhabi Investment Fund Morgan Stanley Apax Global Kuwait Investment Authority Grandeur Peak International DB International ICICI Prudential Mutual Fund HDFC Mutual Fund SBI Mutual Fund Franklin Mutual Fund Kotak Mutual Fund Reliance Mutual Fund IDFC Mutual Fund DB International Kuwait Investment Authority Apax Group Morgan Stanley Abu Dhabi Investment Authority |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|